SCHEMBL7345385

SCHEMBL7345385

COc1ccc2[nH]c(Cl)nc2c1C

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 2/20 0.45
NPC1 O15118 1/20 0.45
ALDH1A1 P00352 4/20 0.39
MEN1 O00255 3/20 0.36
KMT2A Q03164 3/20 0.36
KDM4E B2RXH2 2/20 0.36
POLB P06746 2/20 0.36
CCNB2 O95067 1/20 0.36
CDK1 P06493 1/20 0.36
CCNB1 P14635 1/20 0.36
GSK3A P49840 1/20 0.36
GSK3B P49841 1/20 0.36
CDK5 Q00535 1/20 0.36
CDK5R1 Q15078 1/20 0.36
CCNB3 Q8WWL7 1/20 0.36
HPGD P15428 1/20 0.36
GAA P10253 2/20 0.36
MGAM O43451 1/20 0.36
SI P14410 1/20 0.36
MGAM2 Q2M2H8 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4689071 0.79 CCNB2 (0.36) ALDH1A1MEN1KMT2AKDM4EPOLB
SCHEMBL1192237 0.78 NPC1 (0.50) RAB9ANPC1ALDH1A1KDM4EGAA
SCHEMBL941420 0.77 HPGD (0.54) RAB9ANPC1ALDH1A1MEN1KMT2A
SCHEMBL6031259 0.75 NPC1 (0.47) RAB9ANPC1ALDH1A1GAAMGAM
SCHEMBL7345392 0.72 PDE3B (0.42) ALDH1A1MEN1KMT2AKDM4EPOLB
SCHEMBL1286019 0.72 TSHR (0.43) ALDH1A1GAAMGAMSIMGAM2
SCHEMBL1128497 0.72 NPC1 (0.45) RAB9ANPC1GAAMGAMSI
SCHEMBL7341936 0.72 ACHE (0.39) RAB9ANPC1ALDH1A1MEN1KMT2A
SCHEMBL6032151 0.71 NPC1 (0.44) RAB9ANPC1MEN1KMT2APOLB
SCHEMBL24549176 0.70 HTT (0.43) RAB9ANPC1ALDH1A1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5436240-A Schizophrenia, Parkinson's disease, depression or hypotensive agents using tricyclic amines THE UPJOHN COMPANY (US) 1995-07-25 US disclosed
EP-0480939-B1 HETEROCYCLIC AMINES HAVING CENTRAL NERVOUS SYSTEM ACTIVITY UPJOHN CO (US) 1995-01-25 EP disclosed
US-5273975-A Heterocyclic amines having central nervous system activity THE UPJOHN COMPANY (US) 1993-12-28 US disclosed
EP-0480939-A1 HETEROCYCLIC AMINES HAVING CENTRAL NERVOUS SYSTEM ACTIVITY. UPJOHN CO (US) 1992-04-22 EP disclosed
WO-1990015058-A1 HETEROCYCLIC AMINES HAVING CENTRAL NERVOUS SYSTEM ACTIVITY THE UPJOHN COMPANY (US) 1990-12-13 WO disclosed